pharmaceutical companies

See the following -

Knowledge-Sharing Platforms Emerge From Life Science Research Collaboration

David Raths | KMWorld | March 1, 2013

One of the hottest topics at life science conferences these days is collaboration. For budgetary reasons, pharmaceutical companies that 10 or 15 years ago would have handled every aspect of research and development in-house have externalized those services to academic partners and outsourced service providers. Read More »

"More Marketing Than Science" - An Anonymous Confession About Deceptive Marketing Published in the British Medical Journal

Roy M. Poses | Health Care Renewal | June 26, 2012

The British Medical Journal just published an anonymous article by a pharmaceutical company insider that explained once again how pharmaceutical companies turn research studies, apparently scholarly articles, and medical education into stealth marketing efforts. Read More »

ABLE, DUKE And OSHL Conduct Workshop On Meeting The Challenges Of Developing New Anticancer Therapies

Press Release | Association of Biotechnology Led Enterprises (ABLE), Duke University , Open Source Health Laboratories (OSHL) | September 17, 2012

Strategic planning, clinical trial initiatives, translational research, and regulatory elements of the drug development process were discussed

Read More »

America’s Healthcare Secret Pricing Scandal Exposed

For everyone who is literally sick and tired of being held ransom by a corrupt healthcare system where insurance companies, their lobbyists, hospital networks, and pharmaceutical companies have had the upper hand by keeping us in the pricing dark, Pratter believes it is time for the unsustainability and unfairness of secret pricing and crippling “surprise” medical bills to stop. This article exposes America’s secret pricing scandal like never before and how it is carefully and purposefully crafted. A review of several self-insured companies’ medical bills has led to the following conclusions. They call their pricing proprietary. We call it secret and unethical. Take your secretly priced anti-nausea medicine and keep reading.

Read More »

Animal Antibiotics: FDA Rules Criticized As Weak As McDonald's

Ben Elgin and Andrew Martin | Bloomberg Businessweek | January 2, 2014

A delegation of public-health advocates filed into the suburban Chicago headquarters of McDonald’s (MCD) last January to deliver a tough message: A decade after the fast-food giant’s groundbreaking promise to reduce medically important antibiotics fed to the animals it buys, the policy had glaring loopholes and was having a questionable impact. Read More »

Antibiotic Use On The Farm: Are We Flying Blind?

Dan Charles | NPR | August 29, 2013

There's a heated debate over the use of antibiotics in farm animals. Critics say farmers overuse these drugs; farmers say they don't. Read More »

Can Data Provide the Trust we Need in Health Care?

One of the problems dragging down the US health care system is that nobody trusts one another. Most of us, as individuals, place faith in our personal health care providers, which may or may not be warranted. But on a larger scale we’re all suspicious of each other... Read More »

CareSet Systems Announces New Data Science Products to Aid Drug Launches

Press Release | Careset Systems | October 19, 2016

CareSet Systems today introduced four new dynamic data science products to aid new drug launches. CareSet is the only company that offers 100% of Medicare A, B, and D claims data over six years to guide the introduction of new drugs and currently serves several big pharmaceutical companies with customized data science products derived from Medicare data. “During the last 3 months, our team has spoken with countless people across the pharmaceuticals industry to understand the unmet needs that 100% Medicare claims analysis can address,” says CareSet Systems CEO, Laura Shapland.

Read More »

Clinovo Announces New Customer Win For Its ClinCapture Open-Source Electronic Data Capture System

Press Release | Clinovo | June 28, 2013

Leading Pharmaceutical Company Starts Phase II Ophthalmology Clinical Trial With Silicon Valley based CRO Clinovo for Electronic Data Capture (EDC), Clinical Data Management (CDM), Biostatistics, and Medical Writing Services Read More »

Clinovo Launches New Version Of CDISC® Express, Its CDISC SDTM Mapping Tool

Press Release | Clinical Data Interchange Standards Consortium (CDISC), Clinovo | August 27, 2013

Downloaded Over 900 Times Globally, Clinovo Releases CDISC Express version 1.1, its SAS-based CDISC SDTM Conversion Tool, adding additional domains and following the new SDTM 3.1.3 specifications. Read More »

Clinovo Presents Next Generation Cloud-Based eClinical System At Venture Capital Conference

Press Release | Clinovo | February 5, 2014

Clinovo will present its vision for CloudClinica, the next generation cloud-based platform for clinical trials, at the 30th Annual Investors Choice Venture Capital Conference on Thursday, February 6th in Salt Lake City, Utah. Read More »

CSIR, Royal Society Of Chemistry Team Up To Support OSDD Efforts: Minister

Staff Writer | Pharmabiz.com | August 9, 2013

Council of Scientific and Industrial Research (CSIR)  had signed a memorandum of understanding (MoU) with Royal Society of Chemistry of London to support  drug discovery efforts through the Open Source Drug Discovery (OSDD) , the Parliament has been told. Read More »

Dazed And Confused: Drugs In Drinking Water

David Bard | The Allegiant | February 16, 2013

Drugs in Drinking Water: There is an unhealthy cocktail of drugs in your drinking water. With each sip, you self-medicate with anti-anxiety and even psychotropic drugs. Read More »

Doctors And Hospitals Got At Least $3.5 Billion From Industry In Just Five Months

Julia Belluz | Vox | September 30, 2014

...Lawsuits in recent years revealed that doctors' relationships with industry can alter their prescribing practices and decision-making for the worse, and pharmaceutical companies have paid out billions of dollars in fines for fraudulent marketing practices...

Read More »

Doctors Denounce Cancer Drug Prices Of $100,000 A Year

Andrew Pollack | New York Times | April 25, 2013

With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down. Read More »